Taxonomic group: bacteria / Proteobacteria
(Phylum: Proteobacteria)
Associated disease: infection due to Escherichia coli [ICD11:
XN6P4 
]
The structure was elucidated in this paperNCBI PubMed ID: 11521094Journal NLM ID: 9433350Publisher: Maney Publishing
Correspondence: uzaehr

fz-borstel.de
Institutions: Research Center Borstel, Center for Medicine and Biosciences, Borstel, Germany
We here report on the structural analysis of a novel tetra-acyl lipid A (LA (tetra)) isolated from Escherichia coli deep rough (Re)-mutant strain F515. In addition to the biologically active hexa-acyl E. coli- type lipid A (compound 506), this incompletely acylated lipid A was found to be also present in the native LPS. Its structure was studied without further derivatisation by chemical analysis, matrix-assisted laser desorption/ionization mass spectrometry, and one- and two- dimensional (1)H- and (13)C-NMR spectroscopy. It was found to be structurally distinct from the tetra-acyl lipid A biosynthetic precursor Ia (compound 406) in lacking the primary (R)-3- hydroxytetradecanoic acid 14:0(3-OH) in position 3' ester-linked to the 'non-reducing' glucosamine (GlcN II). The hydroxyl group at the (R)-3- hydroxytetradecanoic acid attached to position 2' of GlcN II was found to be substituted by dodecanoic acid (12:0), thus forming a dodecanoyloxytetradecanoyl residue 14:0[3-O(12:0)]. The acylation pattern at the 'reducing' GlcN I was identical to that of compound 406 in having two primary (R)-3-hydroxy tetradecanoic acid residues [14:0(3- OH)] attached to positions 3 (ester-linked) and 2 (amide-linked), respectively. In human mononuclear cells (hMNC) the new LA (tetra) antagonized LPS-induced release of interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor (TNF) in a dose-dependent manner with identical antagonistic potency as compared with compound 406. Also like compound 406, it was found to be an agonist in murine macrophage-like J774.1 cells.
Lipopolysaccharide, Escherichia coli, lipid A, mass spectrometry, spectroscopy
Structure type: oligomer
Location inside paper: p.141, fig.6, LAtetra
Compound class: lipid A
Contained glycoepitopes: IEDB_135394,IEDB_141807,IEDB_151531,IEDB_534864
Methods: 13C NMR, 1H NMR, NMR-2D, TLC, 31P NMR, GLC, mild acid hydrolysis, MALDI-TOF MS, biological assays, composition analysis, NMR-1D, extraction
Comments, role: LA-tetra isolated from E. coli (Re)-mutant strain F515.
Related record ID(s): 5951
NCBI Taxonomy refs (TaxIDs): 562
Show glycosyltransferases
NMR conditions: in DMSO-d6 at 320 K
[as TSV]
13C NMR data:
Linkage Residue C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 C12 C13 C14
0,2 lR3HOMyr 171.66 44.13 67.10 ? ? ? ? ? ? ? ? ? ? ?
0,3 lR3HOMyr 171.33 42.90 67.24 ? ? ? ? ? ? ? ? ? ? ?
0,6,2,3 lXLau 172.3 ? ? ? ? ? ? ? ? ? ? ?
0,6,2 lR3HOMyr 169.13 40.75 71.11 33.41 ? ? ? ? ? ? ? ? ? ?
0,6,4 P
0,6 bDGlcpN 100.73 55.81 73.72 73.45 75.93 61.30
0 aDGlcpN 92.88 52.08 73.72 68.24 73.45 67.52
P
1H NMR data:
Linkage Residue H1 H2 H3 H4 H5 H6 H7 H8 H9 H10 H11 H12 H13 H14
0,2 lR3HOMyr - 2.10-? 3.71 ? 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 0.86
0,3 lR3HOMyr - 2.31-2.36 3.81 ? 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 0.86
0,6,2,3 lXLau - 2.24 1.55 1.65 1.25 1.25 1.25 1.25 1.25 1.25 1.25 0.86
0,6,2 lR3HOMyr - 2.44-? 5.12 1.55 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 0.86
0,6,4 P
0,6 bDGlcpN 4.66 3.47 3.56 3.71 3.21 3.58
0 aDGlcpN 5.30 3.88 4.99 3.36 3.87 3.82
P
1H/13C HSQC data:
Linkage Residue C1/H1 C2/H2 C3/H3 C4/H4 C5/H5 C6/H6 C7/H7 C8/H8 C9/H9 C10/H10 C11/H11 C12/H12 C13/H13 C14/H14
0,2 lR3HOMyr 44.13/2.10-? 67.10/3.71 ?/? ?/1.25 ?/1.25 ?/1.25 ?/1.25 ?/1.25 ?/1.25 ?/1.25 ?/1.25 ?/1.25 ?/0.86
0,3 lR3HOMyr 42.90/2.31-2.36 67.24/3.81 ?/? ?/1.25 ?/1.25 ?/1.25 ?/1.25 ?/1.25 ?/1.25 ?/1.25 ?/1.25 ?/1.25 ?/0.86
0,6,2,3 lXLau ?/2.24 ?/1.55 ?/1.65 ?/1.25 ?/1.25 ?/1.25 ?/1.25 ?/1.25 ?/1.25 ?/1.25 ?/0.86
0,6,2 lR3HOMyr 40.75/2.44-? 71.11/5.12 33.41/1.55 ?/1.25 ?/1.25 ?/1.25 ?/1.25 ?/1.25 ?/1.25 ?/1.25 ?/1.25 ?/1.25 ?/0.86
0,6,4 P
0,6 bDGlcpN 100.73/4.66 55.81/3.47 73.72/3.56 73.45/3.71 75.93/3.21 61.30/3.58
0 aDGlcpN 92.88/5.30 52.08/3.88 73.72/4.99 68.24/3.36 73.45/3.87 67.52/3.82
P
1H NMR data:
| Linkage | Residue | H1 | H2 | H3 | H4 | H5 | H6 | H7 | H8 | H9 | H10 | H11 | H12 | H13 | H14 |
| 0,2 | lR3HOMyr |
| 2.10 ? | 3.71 | ? | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 | 0.86 |
| 0,3 | lR3HOMyr |
| 2.31 2.36 | 3.81 | ? | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 | 0.86 |
| 0,6,2,3 | lXLau |
| 2.24 | 1.55 | 1.65 | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 | 0.86 | |
| 0,6,2 | lR3HOMyr |
| 2.44 ? | 5.12 | 1.55 | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 | 0.86 |
| 0,6,4 | P | |
| 0,6 | bDGlcpN | 4.66 | 3.47 | 3.56 | 3.71 | 3.21 | 3.58 | |
| 0 | aDGlcpN | 5.30 | 3.88 | 4.99 | 3.36 | 3.87 | 3.82 | |
| | P | |
|
13C NMR data:
| Linkage | Residue | C1 | C2 | C3 | C4 | C5 | C6 | C7 | C8 | C9 | C10 | C11 | C12 | C13 | C14 |
| 0,2 | lR3HOMyr | 171.66 | 44.13 | 67.10 | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? |
| 0,3 | lR3HOMyr | 171.33 | 42.90 | 67.24 | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? |
| 0,6,2,3 | lXLau | 172.3 | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | |
| 0,6,2 | lR3HOMyr | 169.13 | 40.75 | 71.11 | 33.41 | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? |
| 0,6,4 | P | |
| 0,6 | bDGlcpN | 100.73 | 55.81 | 73.72 | 73.45 | 75.93 | 61.30 | |
| 0 | aDGlcpN | 92.88 | 52.08 | 73.72 | 68.24 | 73.45 | 67.52 | |
| | P | |
|
 The spectrum also has 43 signals at unknown positions (not plotted). |
There is only one chemically distinct structure: